Evidence map›Paper›PMID 30587772›Full record

ReviewInternational journal of molecular sciences2018

The Role of APOE and TREM2 in Alzheimer's Disease-Current Understanding and Perspectives.

Cody M Wolfe, Nicholas F Fitz, Kyong Nyon Nam, Iliya Lefterov, Radosveta Koldamova

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 3 syntheses or guidelines pooled it, 189 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. International journal of molecular sciences · 2025
    Review
  20. Review

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cody M WolfeDepartment of Environmental & Occupational Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. cody.wolfe@pitt.edu.ORCID 0000-0003-2874-4944
Nicholas F FitzDepartment of Environmental & Occupational Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. nffitz@pitt.edu.
Kyong Nyon NamDepartment of Environmental & Occupational Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. Kyn5@pitt.edu.
Iliya LefterovDepartment of Environmental & Occupational Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. iliyal@pitt.edu.
Radosveta KoldamovaDepartment of Environmental & Occupational Health, University of Pittsburgh, Pittsburgh, PA 15261, USA. radak@pitt.edu.
University of Pittsburgh · US

Funding

APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2R01AG057565 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLDAMOVA, RADOSVETA, LEFTEROV, ILIYA · 2018 to 2022
$3.2M
Epigenetic and phenotypic effects of arsenic: impacts on cognition and ADR01ES024233 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLDAMOVA, RADOSVETA, LEFTEROV, ILIYA · 2014 to 2018
$2.6M
Age dependent APOE isoform specific effect on immune receptor mediated phagocytosis in brainRF1AG056371 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLDAMOVA, RADOSVETA, LEFTEROV, ILIYA · 2017 to 2018
$2.3M
Peripheral & Brain Cholesterol Metabolism in Neurodegenerative Mouse ModelsK01AG044490 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FITZ, NICHOLAS FRANCIS · 2014 to 2018
$463k
Alzheimer's Association AARF-16-443213Foundation for the National Institutes of Health AG056371Foundation for the National Institutes of Health AG057565Foundation for the National Institutes of Health ES024233Foundation for the National Institutes of Health K01AG044490NIA NIH HHS K01 AG044490NIA NIH HHS R01 AG056371NIA NIH HHS R01 AG057565NIA NIH HHS RF1 AG056371NIEHS NIH HHS R01 ES024233U.S. Department of Defense W81XWH-13-1-0384
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the leading cause of dementia worldwide. The extracellular deposits of Amyloid beta (Aβ) in the brain-called amyloid plaques, and neurofibrillary tangles-intracellular tau aggregates, are morphological hallmarks of the disease. The risk for AD is a complicated interplay between aging, genetic risk factors, and environmental influences. One of the Apolipoprotein E (

Indexed as

Alzheimer DiseaseApolipoproteins ECentral Nervous SystemHumansLow Density Lipoprotein Receptor-Related Protein-1Membrane GlycoproteinsMicrogliaProtein BindingProtein IsoformsReceptors, ImmunologicRisk FactorsApolipoproteins ELow Density Lipoprotein Receptor-Related Protein-1Membrane GlycoproteinsProtein IsoformsReceptors, ImmunologicTREM2 protein, humanAlzheimer’s disease (AD)amyloid betaamyloidogenesisApolipoprotein E (APOE)inflammationmicrogliatriggering receptor expressed on myeloid cells 2 (TREM2)tyrobp

Identifiers

PMID30587772
PMCPMC6337314
OpenAlexW2905698223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.